Fetal plasma prolactin levels and fetal growth in relation to maternal CB-154 treatment in the rat.
(1979) General and Comparative Endocrinology — Vol. 39, n° 1, p. 118-120 (1979)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Pregnant Wistar rats received daily injections of 1 mg of CB-154 starting Day 14 of gestation. The CB-154 treatment did not suppress maternal plasma prolactin levels, but a significant decrease in fetal prolactin was seen. This suppression of prolactin levels in fetal plasma however did not influence fetal growth. These results do indicate that prolactin does not act as a growth promoting hormone in fetal rats.
- Affiliations
Citations
Reusens, B., Kühn, E. R., & Hoet, J. J. (1979). Fetal plasma prolactin levels and fetal growth in relation to maternal CB-154 treatment in the rat. General and Comparative Endocrinology, 39(1), 118-120. https://doi.org/10.1016/0016-6480(79)90198-9 (Original work published 1979)